Ellen M. Schultz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ellen M. Schultz has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Kathryn Mack McDonald
Center for Health Policy/Center for Primary Care and Outcomes Research, Stanford University, Stanford, USA
2 shared publications - Christine S. Chang
Agency for Healthcare Research and Quality, Rockville, MD 20850, USA
1 shared publication D K Owens
Stanford School of Medicine, Stanford, California, USA
1 shared publicationE F Patz
Duke University, Durham, NC, United States
1 shared publicationG A Silvestri
Medical University of South Carolina, Charleston, South Carolina, USA
1 shared publicationG D Sanders
Duke University, Durham, North Carolina, USA
1 shared publication
Latest Publications
- 1 December 2013
- Published by The Permanente Federation in The Permanente Journal
- Vol. 17 (4) , 52-61
Evaluating the State of Quality-Improvement Science through Evidence Synthesis: Insights from the Closing the Quality Gap Series
Kathryn M McDonald, MM; Ellen M Schultz, MS; Christine Chang, MD, MPH Perm J 2013 Fall;17(4)52-61 http://dx.doi.org/10.7812/TPP/13-010 Abstract Con
- 1 December 2013
- Published by The Permanente Federation in The Permanente Journal
- Vol. 17 (4) , 52-61
Evaluating the State of Quality-Improvement Science through Evidence Synthesis: Insights from the Closing the Quality Gap Series
Kathryn M McDonald, MM; Ellen M Schultz, MS; Christine Chang, MD, MPH Perm J 2013 Fall;17(4)52-61 http://dx.doi.org/10.7812/TPP/13-010 Abstract Con
- Open Access
- 28 March 2013
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 119
A systematic review of the care coordination measurement landscape
Care coordination has increasingly been recognized as an important aspect of high-quality health care delivery. Robust measures of coordination processes will be essential tools to evaluate, guide and support efforts to understand and improve coordination, yet little agreement exists among stakeholders about how to best measure care coordination. We aimed to review and characterize existing measures of care coordination processes and identify areas of high and low density to guide future measure development.
- 28 March 2013
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 119
Open AccessA systematic review of the care coordination measurement landscape
Care coordination has increasingly been recognized as an important aspect of high-quality health care delivery. Robust measures of coordination processes will be essential tools to evaluate, guide and support efforts to understand and improve coordination, yet little agreement exists among stakeholders about how to best measure care coordination. We aimed to review and characterize existing measures of care coordination processes and identify areas of high and low density to guide future measure development.
- Open Access
Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules
Background: Effective strategies for managing patients with solitary pulmonary nodules (SPN) depend critically on the pre-test probability of malignancy. Objective: To validate two previously developed models that estimate the probability that an indeterminate SPN is malignant, based on clinical characteristics and radiographic findings. Methods: Data on age, smoking and cancer history, nodule size, location and spiculation were collected retrospectively from the medical records of 151 veterans (145 men, 6 women; age range 39–87 years) with an SPN measuring 7–30 mm (inclusive) and a final diagnosis established by histopathology or 2-year follow-up. Each patient’s final diagnosis was compared with the probability of malignancy predicted by two models: one developed by investigators at the Mayo Clinic and the other developed from patients enrolled in a VA Cooperative Study. The accuracy of each model was assessed by calculating areas under the receiver operating characteristic (ROC) curve and the models were calibrated by comparing predicted and observed rates of malignancy. Results: The area under the ROC curve for the Mayo Clinic model (0.80; 95% CI 0.72 to 0.88) was higher than that of the VA model (0.73; 95% CI 0.64 to 0.82), but this difference was not statistically significant (Δ = 0.07; 95% CI −0.03 to 0.16). Calibration curves showed that the probability of malignancy was underestimated by the Mayo Clinic model and overestimated by the VA model. Conclusions: Two existing prediction models are sufficiently accurate to guide decisions about the selection and interpretation of subsequent diagnostic tests in patients with SPNs, although clinicians should also consider the prevalence of malignancy in their practice setting when choosing a model.
Open AccessValidation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules
Background: Effective strategies for managing patients with solitary pulmonary nodules (SPN) depend critically on the pre-test probability of malignancy. Objective: To validate two previously developed models that estimate the probability that an indeterminate SPN is malignant, based on clinical characteristics and radiographic findings. Methods: Data on age, smoking and cancer history, nodule size, location and spiculation were collected retrospectively from the medical records of 151 veterans (145 men, 6 women; age range 39–87 years) with an SPN measuring 7–30 mm (inclusive) and a final diagnosis established by histopathology or 2-year follow-up. Each patient’s final diagnosis was compared with the probability of malignancy predicted by two models: one developed by investigators at the Mayo Clinic and the other developed from patients enrolled in a VA Cooperative Study. The accuracy of each model was assessed by calculating areas under the receiver operating characteristic (ROC) curve and the models were calibrated by comparing predicted and observed rates of malignancy. Results: The area under the ROC curve for the Mayo Clinic model (0.80; 95% CI 0.72 to 0.88) was higher than that of the VA model (0.73; 95% CI 0.64 to 0.82), but this difference was not statistically significant (Δ = 0.07; 95% CI −0.03 to 0.16). Calibration curves showed that the probability of malignancy was underestimated by the Mayo Clinic model and overestimated by the VA model. Conclusions: Two existing prediction models are sufficiently accurate to guide decisions about the selection and interpretation of subsequent diagnostic tests in patients with SPNs, although clinicians should also consider the prevalence of malignancy in their practice setting when choosing a model.
- 1 April 2008
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 3 (4) , 422-426
Variation in Experts’ Beliefs about Lung Cancer Growth, Progression, and Prognosis
- 1 April 2008
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 3 (4) , 422-426
Variation in Experts’ Beliefs about Lung Cancer Growth, Progression, and Prognosis